Biolaser ApS: Financial statements 2025
CVR: 21333271
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Biolaser ApS (CVR 21333271) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -133,181 and a net result of DKK -141,615 compared with DKK 82,521 the year before. Equity in the 2025 report amounted to DKK 685,450. The solvency ratio was 68.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -133,181
- Profit/Loss
- DKK -141,615
- Equity
- DKK 685,450
- Total Assets
- DKK 1,007,187
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -133 t. | -142 t. | 685 t. | 1 |
| 2024 | - | 209 t. | 83 t. | 827 t. | 1 |
| 2023 | - | -47 t. | -37 t. | 745 t. | - |
| 2022 | - | 614 t. | 479 t. | 1.3 mio. | - |
| 2021 | - | 318 t. | 248 t. | 1.1 mio. | 0 |
Official annual report
How creditworthy is Biolaser ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Biolaser ApS has published its annual report for 2024. Gross profit came to DKK 209,010, and the net result was DKK 82,521.
About Biolaser ApS
Biolaser ApS is a Danish company of the type Anpartsselskab based in Fjerritslev, founded in 1998. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Caitanya Candradasa. The company is owned by Caitanya Candradasa. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -133,181 and a net result of DKK -141,615 compared with DKK 82,521 the year before. Equity in the 2025 report amounted to DKK 685,450.